RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis

Quazi T. H. Shubhra

doi:10.1186/s40779-023-00480-w

Your Location：

Home >

Browse articles >

RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis

COMMENTARY | Updated：2025-12-13

- RARRES2's impact on lipid metabolism in triple- negative breast cancer: a pathway to brain metastasis
- Military Medical Research Vol. 11, Issue 2, Pages: 311-312(2024)
- Affiliations：
  
  1.Institute of Chemistry, University of Silesia in Katowice, 41-500 Chorzów, Poland
  2.Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
- Author bio：
  
  *tanminul-haque-shubra.quazi@us.edu.pl; shubhro.du@gmail.com
- Funds：
- DOI：10.1186/s40779-023-00480-w
  CLC：
- Published：2024-04
- Accepted：
Scan QR Code
Cite this article as: Shubhra QTH. RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis. Mil Med Res. 2023;10(1):42.
DOI：

Cite this article as: Shubhra QTH. RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis. Mil Med Res. 2023;10(1):42. DOI： 10.1186/s40779-023-00480-w.

摘要

Abstract

关键词

Keywords

references

Li YQ , Sun FZ , Li CX , Mo HN , Zhou YT , Lv D , et al . RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer . Mil Med Res . 2023 ; 10 ( 1 ): 34 .

Guo K , Xiao N , Liu Y , Wang Z , Tóth J , Gyenis J , et al . Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: opportunities and challenges . Nano Mater Sci . 2022 ; 4 ( 4 ): 295 – 321 .

Sirhan Z , Thyagarajan A , Sahu RP . The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer . Mil Med Res . 2022 ; 9 ( 1 ): 39 .

Ernst MC , Sinal CJ . Chemerin: at the crossroads of inflammation and obesity . Trends Endocrinol Metab . 2010 ; 21 ( 11 ): 660 – 7 .

Rennier K , Shin WJ , Krug E , Virdi G , Pachynski RK . Chemerin reactivates PTEN and suppresses PD-L1 in tumor cells via modulation of a novel CMKLR1-mediated signaling cascade . Clin Cancer Res . 2020 ; 26 ( 18 ): 5019 – 35 .

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Unresolved questions in the application of artificial intelligence virtual cells for cancer research

Impact of targeting the platelet-activating factor and its receptor in cancer treatment

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease

Association between periodontal disease and systemic diseases: a cross-sectional analysis of current evidence

Related Author

Carlos M. Ardila

Pradeep K. Yadalam

Kimya Qaderi

Arvin Shahmoradi

Anita Thyagarajan

Ravi P. Sahu

Yogesh Godiyal

Drishti Maheshwari

Related Institution

Department of Basic Sciences, Saveetha Dental College, SIMATS, Saveetha University

Department of Basic Sciences, Biomedical Stomatology Research Group, Faculty of Dentistry, Universidad de Antioquia, U de A

Department of Molecular and Cell Biology, College of Life Sciences, University of Leicester, University Road

Department of Laboratory Medicine, Faculty of Paramedical, Kurdistan University of Medical Sciences

Department of Pharmacology and Toxicology, Boonshoft School of Medicine Wright State University

⁰